Regenerative medicine has been a recent clinical advancement in addressing the unmet need in orthopedic injury. There have been significant clinical and basic science advancements in technology and delivery strategy. This course brings together leading experts to discuss these advancements across multiple domains including stem cell-derived therapies, autologous blood-derived therapies, and gene transfer strategies.

Learning Objectives

Upon completion of this course, participants will be able to:

Recognize and apply general principles in choosing the appropriate regenerative treatment for musculoskeletal conditions.

Explain the basic science of platelet-rich plasma and stem cell therapies in the treatment of degenerative musculoskeletal conditions.

Define the current FDA position regarding the use of stem cell and platelet-rich plasma therapies and the restrictions in the use of these treatments in clinical practice.

Explain the current clinical evidence to support the use of platelet-rich plasma and mesenchymal cell treatment.

Acquire the skills and outline the steps to harvest platelets and stem cells from bone marrow and adipose tissue, including appropriate sterile techniques, proper anesthesia and pain control as well as recognize the risks of these procedures.

Determine the basic skill set required to perform stem cell therapies, including appropriate history and physical examination, anatomical surface anatomy, and radiographic and ultrasound anatomy.

A Word From Our Course Directors

We invite practitioners, who seek an understanding of the latest technologies and applications in the rapidly-evolving field of regenerative medicine, to increase their knowledge and expertise in this exciting area of medicine. Learn from leading experts how regenerative interventions can be optimized in the treatment of degenerative musculoskeletal conditions.

— Drs. Jayaram and Malanga

Who Should Attend?

Physicians who wish to advance their knowledge of regenerative treatment options and how to begin to incorporate these treatments into their practice. This course is offered only to doctors of medicine or doctors of osteopathy.

Accreditation

The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The American Academy of Physical Medicine and Rehabilitation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Lecture Topics Include:

Rationale for regenerative interventions in orthopedics and sports medicine

Status of and utility in prolotherapy in a regenerative clinical practice

Academy Tested, Board Approved!

The 2018 Annual Assembly Preconference Courses have been approved by the American Board of Physical Medicine and Rehabilitation (ABPMR) for Maintenance of Certification® (MOC®) Part II Self-Assessment credit. Attendees must complete a post-test to earn AMA PRA Category 1 Credits™, which will be commensurate with the number of CME available for each precourse.